RENVELA
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $25,664 | 8 | 1 |
| 2018 | $266.62 | 14 | 14 |
| 2017 | $132,149 | 2,266 | 1,246 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,829 | 10 | 50.5% |
| Food and Beverage | $40,183 | 2,244 | 25.4% |
| Travel and Lodging | $27,238 | 24 | 17.2% |
| Unspecified | $5,498 | 7 | 3.5% |
| Consulting Fee | $5,332 | 3 | 3.4% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease | GENZYME CORPORATION | $5,498 | 7 |
Top Doctors Receiving Payments for RENVELA — Page 47
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Kenneth Kellum | — | Tupelo, MS | $12.61 | 1 |
| , M.D | Geriatric Medicine | Warner Robins, GA | $12.56 | 1 |
| , M.D, FASN, FNKF | Nephrology | Gallipolis, OH | $12.55 | 1 |
| , M.D | Internal Medicine | Yorktown Heights, NY | $12.53 | 1 |
| , MD | Internal Medicine | Tullahoma, TN | $12.53 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Temple Terrace, FL | $12.52 | 1 |
| , M.D | Specialist | Brandon, FL | $12.52 | 1 |
| , MD | Nephrology | Southfield, MI | $12.49 | 1 |
| , M.D | Internal Medicine | Lafayette, LA | $12.48 | 1 |
| , M.D | Internal Medicine | Saginaw, MI | $12.47 | 1 |
| , M.D | Nephrology | Los Angeles, CA | $12.46 | 1 |
| , M.D | Anesthesiology | Lexington, KY | $12.46 | 1 |
| , M.D | Nephrology | Southfield, MI | $12.45 | 1 |
| , D.O | Nephrology | Lima, OH | $12.45 | 1 |
| , MD | Nephrology | Elk Grove Village, IL | $12.44 | 1 |
| , MD | Nephrology | Florence, SC | $12.43 | 1 |
| , MD | Nephrology | Gurnee, IL | $12.43 | 1 |
| , M.D | Nephrology | Rochester, NY | $12.42 | 1 |
| , M.D | Nephrology | Youngstown, OH | $12.40 | 1 |
| , M.D | Internal Medicine | Winston-Salem, NC | $12.34 | 1 |
| , DO | Nephrology | Columbus, OH | $12.34 | 1 |
| , M.D | Nephrology | Greenville, NC | $12.31 | 1 |
| , M.D | Nephrology | Greenville, NC | $12.31 | 1 |
| , MD | Internal Medicine | Bismarck, ND | $12.30 | 1 |
| , MD | Nephrology | Joliet, IL | $12.26 | 1 |
Manufacturing Companies
- SANOFI-AVENTIS U.S. LLC $131,370
- GENZYME CORPORATION $26,710
Product Information
- Type Drug
- Total Payments $158,080
- Total Doctors 1,251
- Transactions 2,288
About RENVELA
RENVELA is a drug associated with $158,080 in payments to 1,251 healthcare providers, recorded across 2,288 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI-AVENTIS U.S. LLC.
Payment data is available from 2017 to 2019. In 2019, $25,664 was paid across 8 transactions to 1 doctors.
The most common payment nature for RENVELA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,829, 50.5% of total).
RENVELA is associated with 1 research study, including "Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease" ($5,498).